NCT00061425View on ClinicalTrials.gov

Treatment of Non-Hodgkin's Lymphoma With 90Y-hLL2 IgG

PHASE1/PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 2000

Primary Completion Date

November 30, 2007

Conditions
Non-Hodgkin's LymphomaLymphoma, B-Cell
Interventions
DRUG

radiolabeled epratuzumab

Sponsors

Lead Sponsor

Gilead Sciences
All Listed Sponsors
lead

Gilead Sciences

INDUSTRY